I
In2Bones
Innovative french company specialising in the design and manufacture of medical devices intended for use in surgery
About In2Bones
In2Bones SAS operates within the medical device sector, specifically focusing on extremity orthopedics for upper and lower limbs. The company was established in 2018 in Ecully, near Lyon, France. Its foundation is the result of a collaboration between a team of engineers and respected surgeons in the field. This partnership aims to develop and market implants and instruments for bone surgery, particularly for hands, feet, and ankles.
Read full description
The business model centers on the design, manufacturing, and distribution of these specialized orthopedic devices. In2Bones serves healthcare professionals, including orthopedic surgeons and hospitals, providing them with the necessary tools for various surgical procedures. The company generates revenue through the sale of its product portfolio to this client base. The market is the global orthopedic extremity segment, with a significant presence in France and the United States through its subsidiary, In2Bones USA, based in Memphis, Tennessee.
The product line includes a range of implants such as screws, plates, and nails, as well as associated instrumentation designed for precision and ease of use in surgery. For instance, the company offers specific solutions like the AlloAid PIP for finger joint fusions and the CoLink View Mfx for midfoot fracture plating systems. A key aspect of their product development is the emphasis on sterile-packaged, single-use instrument kits. This approach aims to improve operating room efficiency, reduce the risk of surgical site infections, and provide cost-effective solutions for healthcare facilities by eliminating the need for reprocessing.
At a glance
- Founded
- 2011
- Headquarters
- Memphis, United States
- Sector
- Health Tech & Medtech
- Power Law
- Colt$25–100M revenue
Latest news
Press, funding announcements and product moves mentioning In2Bones.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Andera Partners
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Market sentiment
An AI-synthesised read of the highest-engagement posts about In2Bones on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See In2Bones on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.